COYA
Price
$5.96
Change
-$0.13 (-2.13%)
Updated
Nov 13 closing price
Capitalization
124.08M
Intraday BUY SELL Signals
TRDA
Price
$8.78
Change
+$0.77 (+9.61%)
Updated
Nov 13 closing price
Capitalization
336.14M
124 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COYA vs TRDA

Header iconCOYA vs TRDA Comparison
Open Charts COYA vs TRDABanner chart's image
Coya Therapeutics
Price$5.96
Change-$0.13 (-2.13%)
Volume$211.23K
Capitalization124.08M
Entrada Therapeutics
Price$8.78
Change+$0.77 (+9.61%)
Volume$650.97K
Capitalization336.14M
COYA vs TRDA Comparison Chart in %
COYA
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
COYA vs. TRDA commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Hold and TRDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (COYA: $5.96 vs. TRDA: $8.78)
Brand notoriety: COYA and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 112% vs. TRDA: 227%
Market capitalization -- COYA: $124.08M vs. TRDA: $336.14M
COYA [@Biotechnology] is valued at $124.08M. TRDA’s [@Biotechnology] market capitalization is $336.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than COYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 2 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • COYA’s TA Score: 2 bullish, 9 bearish.
  • TRDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than COYA.

Price Growth

COYA (@Biotechnology) experienced а +3.47% price change this week, while TRDA (@Biotechnology) price change was +26.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.64%. For the same industry, the average monthly price growth was -3.56%, and the average quarterly price growth was +66.73%.

Reported Earning Dates

TRDA is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+3.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($336M) has a higher market cap than COYA($124M). COYA YTD gains are higher at: 4.014 vs. TRDA (-49.219). COYA has higher annual earnings (EBITDA): -22.59M vs. TRDA (-92.26M). TRDA has more cash in the bank: 354M vs. COYA (29.8M). TRDA has higher revenues than COYA: TRDA (79.5M) vs COYA (423K).
COYATRDACOYA / TRDA
Capitalization124M336M37%
EBITDA-22.59M-92.26M24%
Gain YTD4.014-49.219-8%
P/E RatioN/A10.26-
Revenue423K79.5M1%
Total Cash29.8M354M8%
Total DebtN/A54.7M-
TECHNICAL ANALYSIS
Technical Analysis
COYATRDA
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHGCF53.463.12
+6.20%
Chugai Pharmaceutical Co., Ltd.
CSBB49.26N/A
N/A
CSB Bancorp, Inc.
RUSMF28.59N/A
N/A
Russel Metals Inc.
DNPLY8.44-0.09
-1.02%
Dai Nippon Printing Co. Ltd.
IRVRF0.17-0.01
-2.94%
Irving Resources Inc

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with GANX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then GANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
-2.13%
GANX - COYA
42%
Loosely correlated
+1.36%
KNSA - COYA
42%
Loosely correlated
-0.71%
ATXS - COYA
38%
Loosely correlated
-0.88%
BMRN - COYA
34%
Loosely correlated
-1.99%
GPCR - COYA
33%
Poorly correlated
-2.56%
More